TREML2 and Alzheimer disease: Our main finding was that the coding missense mutation of TREML2 (rs3747742-C) was closely related to decreased baseline CSF T-tau concentrations and slower rate of longitudinal changes in CSF T-tau levels during the 4 years follow-up in AD patients.